Duodenal polyposis disclosing mantle-cell lymphoma
Moulin, O.; Boucher, E.; Samson, T.; Coutant, G.; Helie, C.; Algayres, J.-P.
Gastroenterologie Clinique et Biologique 26(11): 1055
2002
ISSN/ISBN: 0399-8320 PMID: 12483144 Document Number: 549804
Document emailed within 1 workday
Related Documents
Soslow, R.A.; Zukerberg, L.R.; Harris, N.L.; Warnke, R.A. 1997: BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(8): 810-817Okamoto, M.; Inaguma, Y.; Okamoto, A. 2019: Ⅳ.Mantle Cell Lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 878-883
Goy, A. 2016: Point: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma: Where It Fits in the New Paradigm Oncology 30(12): 1055-8 1060
Obukhova, T.N.; Lorie, I.Iu.; Vodinskaia, L.A.; Alimova, G.A.; Nikitin, E.A.; Samoĭlova, R.S.; Kaplanskaia, I.B.; Domracheva, E.V. 2004: Cytogenetics of mantle cell lymphoma Terapevticheskii Arkhiv 76(7): 70-77
Intragumtornchai, T.; Rojnuckarin, P.; Sutcharitchan, P.; Wannakrairot, P. 2004: Mantle cell lymphoma in Thai patients Journal of the Medical Association of Thailand 87(9): 1071-1075
Motegi, S.-I.; Okada, E.; Nagai, Y.; Tamura, A.; Ishikawa, O. 2006: Skin manifestation of mantle cell lymphoma European Journal of Dermatology: Ejd 16(4): 435-438
Goy, A. 2013: Update in the management of mantle cell lymphoma Clinical Advances in Hematology and Oncology: H&o 11(5): 297-299
Rosen, S.T.; Link, B.K.; Fowler, N.H. 2013: Unmet needs in the treatment of mantle cell lymphoma Clinical Advances in Hematology and Oncology: H&o 11(11 Suppl 18: 1-19
Ogura, M. 2014: Current treatment strategy in mantle cell lymphoma Nihon Rinsho. Japanese Journal of Clinical Medicine 72(3): 499-511
Chen, R.; Sanchez, J.; Rosen, S.T. 2016: Clinical Management Updates in Mantle Cell Lymphoma Oncology 30(4): 353-360
Alvarez-Argote, J.; Bauer, F.A.; Dasanu, C.A. 2014: CD5 negative mantle cell lymphoma: a different clinical entity? Connecticut Medicine 78(4): 211-214
Uehira, K.; Kagami, Y.; Ogura, M.; Suzuki, R.; Miura, K.; Tachi, H.; Kurokawa, T.; Kinoshita, T.; Murate, T.; Nakamura, S.; Morishima, Y. 1998: A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphoma International Journal of Hematology 67(2): 187-190
Onciu, M.; Schlette, E.; Bueso-Ramos, C.; Medeiros, L.Jeffrey. 2002: Leukemic mantle cell lymphoma with cells resembling prolymphocytes American journal of clinical pathology 118(2): 305-6; author reply 306
Obeso, G.; Rivas, C.; Blanco, I.; Marcos, B.; García Delgado, R.; Echezarreta, G.; Sanz, E.; Castrillo, J.M. 1993: Follicular mantle lymphoma: clinicopathologic and cell proliferation of 11 cases Medicina Clinica 101(11): 406-409
Roisman, A.; Slavutsky, I. 2014: Expression of SOX11 transcription factor. its implication in mantle cell lymphoma Medicina 74(2): 140-146
Pazur, M.; Ostojić, A.; Jelić-Puskarić, B.; Kardum-Skelin, I.; Vrhovac, R.; Gasparov, S.; Trcić, R.L.; Jaksić, B. 2011: Longterm indolent course of pleomorphic mantle cell lymphoma with multiple chromosomal abnormalities Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(Suppl 1): 197-201
Nakamura, S.; Yatabe, Y.; Kuroda, H.; Ueda, R.; Takahashi, T.; Suchi, T.; Seto, M. 1997: Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma Leukemia 11(Suppl 3): 536-537
Jin, Z.; Teramoto, N.; Hayashi, K.; Liu, Y.-X.; Jin, G.; Oka, T.; Takahashi, K.; Yoshino, T.; Akagi, T. 2004: CD40 ligand stimulation inhibits the proliferation of mantle cell lymphoma lines Anticancer Research 24(2b): 691-697
Perrot, J.L.; Colomb, M.; Mazuy, A.; Claudy, A. 1989: Urticaria with hypereosinophilia disclosing malignant T-cell lymphoma Annales de Dermatologie et de Venereologie 116(6-7): 467-469
László, T.; Csernus, B.; Krenács, L.; Kelényi, G.; Matolcsy, A. 1999: Pathologic diagnosis of mantle cell lymphoma based on histologic, cytologic, immunohistologic and genetic characteristics Orvosi Hetilap 140(52): 2907-2912